September 15, 2015

McKesson and Albertsons announced the signing of a five-year distribution agreement to include the sourcing and distribution of both branded and generic pharmaceuticals.

September 14, 2015

Mylan announced Monday that it had launched its generic version of Pfizer’s Unasyn (ampicillin and subactam) injection. 

September 14, 2015

The Perrigo offer notwithstanding, Mylan is committed and well-positioned to pursue the OTC segment independently given its global scale and capabilities, company says. 

September 11, 2015

A new study by healthcare provider Kaiser Permanente’s research division published in the Journal of the American Informatics Association is highlighting the positive effects online prescription refills have on adherence.

September 11, 2015

Using Xerox’s prescription clinical authorization tool, pharmacists can investigate whether a patient recently received an opioid prescription and will receive a notice to acquire prior authorization before dispensing it. 

September 10, 2015

However, patients in the 10-17 years age group also showed the greatest improvement in appropriate prescription drug use compared to all other age groups over a four-year period.

September 10, 2015

As part of the partnership, the two companies will create a joint research team that will use big data and machine learning technology to develop therapeutic solutions and disease models.

September 9, 2015

The research found a 1% increase in overall prescription drug use was associated with decreases in non-prescription drug medical costs for three distinct groups of Medicaid beneficiaries.

September 9, 2015

Customer-to-customer will be the next stage of business model evolution in healthcare, according to Frost & Sullivan.

September 8, 2015

The Centers for Disease Control and Prevention has launced its new program, “Prescription Drug Overdose: Prevention for States,” which aims to invest in 16 states currently battling an epidemic of prescription drug overdoses. 

September 8, 2015

The acquisitions will bring InvaGen’s 32 products and 40 approved abbreviated new drug applications, as well as Exelan’s management team and institutional market under the company’s control. 

September 8, 2015

The drug, which is indicated to treat fundal infections, is available in 50- and 200-mg dosage strengths.

September 8, 2015

Data from recent years suggests that the increasing prevalence of diabetes may be leveling off.

September 8, 2015

Medisafe, a mobile health platform for medication management, on Tuesday announced its partnership with GoodRx, a prescription price comparison platform.

September 8, 2015

 Mylan on Tuesday announced the launch of its generic version of Bayer’s Yasmin (drospirenone and ethinyl estradiol) birth control tablets.

September 8, 2015

Under the terms of the offer, Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share.

September 8, 2015

The program asks individuals living with pain and providers to design the ideal experience in the exam room that would foster dialogue about prescription drug abuse, deterrent technology and the effect of pain.

September 4, 2015

Ancino this week launched its rivastigmine patch, a generic version of the Exelon patch.

September 3, 2015

Lupin Pharmaceuticals on Thursday announced the launch of its duloxetine delayed-release, a generic version of Cymbalta.

September 3, 2015

 The drug, a biosimilar version of Amgen’s Neupogen, is the first biosimilar drug to launch in the U.S.

September 2, 2015

he campaign is being undertaken in partnership with the American Chronic Pain Association, the Pain Community, the U.S. Pain Foundation and the American Academy of Pain Management.

September 2, 2015

Par Pharmaceutical on Wednesday announced that it has begun shipping its generic version of AbbVie’s AnroGel (testosterone gel 1%) in 2.5-g and 5-g foil packets.

September 1, 2015

PrescribeMedicare is meant to serve as a tool for patients in 2016 when open enrollment for plan choices begins.

August 31, 2015

The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.